about
Gemcitabine-cisplatin versus gemcitabine-oxaliplatin doublet chemotherapy in advanced gallbladder cancers: a match pair analysis.Early outcomes of exon 11 mutants in GIST treated with standard dose Imatinib.Treatment of advanced Gall bladder cancer in the real world-can continuation chemotherapy improve outcomes?Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancerOutcome of operable oral cavity cancer and impact of maintenance metronomic chemotherapy: A retrospective study from rural IndiaDihydro pyrimidine dehydrogenase deficiency in patients treated with capecitabine based regimens: a tertiary care centre experience.Multivisceral resections for rectal cancers: short-term oncological and clinical outcomes from a tertiary-care center in India.Restaging after neoadjuvant chemoradiation in rectal cancers: is histology the key in patient selection?Pazopanib in metastatic multiply treated progressive gastrointestinal stromal tumors: feasible and efficacious.Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib.Surgical outcomes of post chemoradiotherapy unresectable locally advanced rectal cancers improve with interim chemotherapy, is FOLFIRINOX better than CAPOX?Oxaliplatin-related neuropathy in Indian patients - no difference between generic and original molecules.Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis.Neoadjuvant Imatinib in Locally Advanced Gastrointestinal stromal Tumours, Will Kit Mutation Analysis Be a Pathfinder?Multidisciplinary management of colorectal adenocarcinoma associated with anal fistula: an Indian series.PET-Based Molecular Imaging in Designing Personalized Management Strategy in Gastroenteropancreatic Neuroendocrine Tumors.Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer.Rectal GIST-Outcomes and viewpoint from a tertiary cancer center.Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual traceRole of adjuvant chemotherapy in T2N0M0 periampullary cancers.Impact of type of surgery (laparoscopic versus open) on the time to initiation of adjuvant chemotherapy in operable rectal cancers.Carcinoembryonic antigen directed PET-CECT scanning for postoperative surveillance of colorectal cancer.The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios.Additional chemotherapy and salvage surgery for poor response to chemoradiotherapy in rectal cancers.Peritoneal Carcinomatosis in Colorectal Cancers - Management Perspective Needs a Change.A Case of Ruptured Adult Embryonal Sarcoma of the Liver with Excellent Outcome After Neoadjuvant Chemotherapy.Observation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: is redifferentiation akin phenomenon a reality in neuroendocrine tumors?Erratum to: A Case of Ruptured Adult Embryonal Sarcoma of the Liver with Excellent Outcome After Neoadjuvant Chemotherapy.Primitive neuroectodermal tumor of ovary in a young lady, confirmed with molecular and cytogenetic results--a rare case report with a diagnostic and therapeutic challenge.Resection of Isolated Port Site Metastasis in Gall Bladder Cancers-Careful Selection and Perioperative Systemic Therapy May Improve OutcomesPulmonary metastasectomy of colorectal cancer origin: Evaluating process and outcomesType B insulin resistance in a systemic lupus erythematosus patientSupportive measures and finer practice points in 177Lu-DOTATATE PRRT for NET: aiming for optimal disease managementSecond-Line Palliative Chemotherapy in Advanced Gall Bladder Cancer, CAP-IRI: Safe and Effective OptionAddition of short course radiotherapy in newly diagnosed locally advanced rectal cancers with distant metastasisReal-World Long-Term Outcomes with Perioperative EOX in D2 Gastrectomy: a Meaningful Look While We Switch to FLOT-4
P50
Q33439321-89EFC70D-F2D4-4422-B0CA-A3FE890855CEQ33575310-621EC1DC-2043-4FD2-A570-200B364D59A2Q33593225-B25DB774-E9BD-491C-885A-5A1A154F957FQ36458249-6583EB77-B1E5-4CD9-AF71-30764D092E00Q36918898-09936CA0-C0C9-4D52-B5AD-FA8FFDE9522EQ36936972-BA2BADA3-9DF2-440D-870B-0FCF80C6EFE1Q36937006-0A60EB79-799A-4A4E-9511-8FEB360FE973Q36937037-F5626399-B842-4D7D-86DF-57027BABF989Q37131708-825ED0E7-7FE6-438A-89C3-E28A080806B0Q37131713-AD41BEBB-9D0F-46B1-BA8C-0DFD36ACE68FQ37525306-AF7AE2EC-9ACF-4F06-BD56-A9449C9F7503Q37584933-A814BC45-E875-4D45-95F6-03891D8BA2E8Q37717181-28A68715-FA67-481C-8A32-7B4C9D3149CFQ38380165-29D4CC21-556A-4581-B919-B01C049EC4F9Q38572129-FF3521BF-10B8-449D-97BB-7C34CFD30C31Q38870146-745F13B0-AC4A-4E86-872D-5C259ACECF51Q38926854-16D43659-BF31-4058-99FD-98AEA90525A1Q39247949-F0EEB9B8-0A02-48C6-8F6E-70015694DBBDQ39723392-B1598E2D-90B3-4126-8241-4E70BF66E199Q40404995-9CC19E0E-ABEE-4ACA-908D-628A49540380Q40657296-66405C73-E2A8-4DCD-9235-A5BA5D853668Q47386125-EF2C393B-4A65-47BF-A053-6D84455F06DAQ48944580-5135425B-5E31-432D-B3E5-643FEAADE43AQ50793187-4C34B700-3BA0-4A81-9328-8099EBEFE621Q51153139-0A4F9D8E-8821-433D-8D96-FEBCB60AF0F3Q52972876-0BD175C7-A0E3-4D05-A496-3D32FF1F02B4Q52983465-661C2736-2C80-43C5-8D84-CE7CE078597CQ53780859-ADD5B1EC-45E6-4B63-A9F4-EC87794B55CCQ54325381-C9AC8D7C-CF57-4CBC-BE9A-02BBB310291CQ57123519-8CC3CBB6-5196-472D-9FD7-291BF2AF3F51Q57453815-B63A9786-DA6A-44E6-8FE5-46E12D8C405FQ84017479-5AF4C121-D333-4ABD-84A5-BAE21E9E4B0CQ85298773-ED9E9AFD-4186-439B-BD2F-56C913BE9EE2Q89257709-97271D39-0C93-4AB0-8922-265428DDE57FQ89588481-5011FFC9-7F95-4774-87C5-C083F9A03817Q92761819-A413ED47-B675-4F8B-821D-D1AD69CAE0CB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vikas Ostwal
@ast
Vikas Ostwal
@en
Vikas Ostwal
@es
Vikas Ostwal
@nl
type
label
Vikas Ostwal
@ast
Vikas Ostwal
@en
Vikas Ostwal
@es
Vikas Ostwal
@nl
prefLabel
Vikas Ostwal
@ast
Vikas Ostwal
@en
Vikas Ostwal
@es
Vikas Ostwal
@nl
P106
P31
P496
0000-0002-0067-4748